AXON
Price
$715.51
Change
-$5.02 (-0.70%)
Updated
Oct 3 closing price
Capitalization
56.17B
32 days until earnings call
GANX
Price
$1.92
Change
+$0.06 (+3.23%)
Updated
Oct 3 closing price
Capitalization
69.02M
33 days until earnings call
Interact to see
Advertisement

AXON vs GANX

Header iconAXON vs GANX Comparison
Open Charts AXON vs GANXBanner chart's image
Axon Enterprise
Price$715.51
Change-$5.02 (-0.70%)
Volume$379.18K
Capitalization56.17B
Gain Therapeutics
Price$1.92
Change+$0.06 (+3.23%)
Volume$644.97K
Capitalization69.02M
AXON vs GANX Comparison Chart in %
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. GANX commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and GANX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (AXON: $715.51 vs. GANX: $1.92)
Brand notoriety: AXON and GANX are both not notable
AXON represents the Aerospace & Defense, while GANX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 61% vs. GANX: 123%
Market capitalization -- AXON: $56.17B vs. GANX: $69.02M
AXON [@Aerospace & Defense] is valued at $56.17B. GANX’s [@Biotechnology] market capitalization is $69.02M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $314.95B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $23.82B. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 2 FA rating(s) are green whileGANX’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 2 green, 3 red.
  • GANX’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while GANX’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 5 bearish.
  • GANX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, GANX is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а +0.94% price change this week, while GANX (@Biotechnology) price change was +7.26% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +4.37%. For the same industry, the average monthly price growth was +12.62%, and the average quarterly price growth was +85.68%.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

AXON is expected to report earnings on Nov 06, 2025.

GANX is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Aerospace & Defense (+4.37% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($56.2B) has a higher market cap than GANX($69M). AXON YTD gains are higher at: 20.391 vs. GANX (-11.111). AXON has higher annual earnings (EBITDA): 341M vs. GANX (-17.16M). AXON has more cash in the bank: 2.23B vs. GANX (6.69M). GANX has less debt than AXON: GANX (681K) vs AXON (2.05B). AXON has higher revenues than GANX: AXON (2.39B) vs GANX (0).
AXONGANXAXON / GANX
Capitalization56.2B69M81,449%
EBITDA341M-17.16M-1,987%
Gain YTD20.391-11.111-184%
P/E Ratio177.47N/A-
Revenue2.39B0-
Total Cash2.23B6.69M33,328%
Total Debt2.05B681K301,175%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
10
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXONGANX
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
48%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCH42.730.53
+1.25%
Invesco S&P SmallCap Health Care ETF
ZALT31.93N/A
N/A
Innovator U.S. Equity 10 Buffr ETF - Qt
NNOV28.50N/A
N/A
Innovator Growth-100 Pwr Buffr ETF - Nov
BOND93.21-0.10
-0.11%
PIMCO Active Bond ETF
NOM10.98-0.07
-0.63%
Nuveen Missouri Quality Municipal Income Fund

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
-0.70%
TECH - AXON
61%
Loosely correlated
+1.39%
VCYT - AXON
58%
Loosely correlated
+1.04%
BEAM - AXON
57%
Loosely correlated
+0.63%
SEER - AXON
56%
Loosely correlated
+3.17%
ADPT - AXON
56%
Loosely correlated
+0.98%
More

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+3.23%
COYA - GANX
38%
Loosely correlated
+3.92%
AXON - GANX
36%
Loosely correlated
-0.70%
EYPT - GANX
35%
Loosely correlated
+1.70%
MDGL - GANX
34%
Loosely correlated
-1.47%
WVE - GANX
34%
Loosely correlated
+1.85%
More